Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02964507 |
| Title | Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | GBR | FRA | ESP | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Birmingham | Alabama | 35249 | United States | Details | |
| GSK Investigational Site | Gilbert | Arizona | 85234 | United States | Details | |
| GSK Investigational Site | Scottsdale | Arizona | 85259 | United States | Details | |
| GSK Investigational Site | San Diego | California | 92123 | United States | Details | |
| GSK Investigational Site | Plantation | Florida | 33324 | United States | Details | |
| GSK Investigational Site | Chicago | Illinois | 60611 | United States | Details | |
| GSK Investigational Site | New Orleans | Louisiana | 70121 | United States | Details | |
| GSK Investigational Site | Rochester | Minnesota | 55905 | United States | Details | |
| GSK Investigational Site | Kansas City | Missouri | 64111 | United States | Details | |
| GSK Investigational Site | Saint Louis | Missouri | 63110 | United States | Details | |
| GSK Investigational Site | Bronx | New York | 10461 | United States | Details | |
| GSK Investigational Site | White Plains | New York | 10601 | United States | Details | |
| GSK Investigational Site | Providence | Rhode Island | 02903 | United States | Details | |
| GSK Investigational Site | Houston | Texas | 77030 | United States | Details | |
| GSK Investigational Site | Seattle | Washington | 98101 | United States | Details | |
| GSK Investigational Site | Port Macquarie | New South Wales | 2444 | Australia | Details | |
| GSK Investigational Site | Bedford Park | South Australia | 5042 | Australia | Details | |
| GSK Investigational Site | Heidelberg | Victoria | 3084 | Australia | Details | |
| GSK Investigational Site | Ottawa | Ontario | K1H 8L6 | Canada | Details | |
| GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| GSK Investigational Site | Montreal | Quebec | H2L 4M1 | Canada | Details | |
| GSK Investigational Site | Montreal | Quebec | H3T 1E2 | Canada | Details | |
| GSK Investigational Site | Quebec | G1S 4L8 | Canada | Details | ||
| GSK Investigational Site | Bordeaux Cedex | 33076 | France | Details | ||
| GSK Investigational Site | Saint-Herblain cedex | 44805 | France | Details | ||
| GSK Investigational Site | Saint-Herblain | 44805 | France | Details | ||
| GSK Investigational Site | Gyeonggi-do | 410-769 | Korea, Republic of | Details | ||
| GSK Investigational Site | Seoul | 120-752 | Korea, Republic of | Details | ||
| GSK Investigational Site | Seoul | 135-710 | Korea, Republic of | Details | ||
| GSK Investigational Site | Seoul | 138-736 | Korea, Republic of | Details | ||
| GSK Investigational Site | A Coruna | 15006 | Spain | Details | ||
| GSK Investigational Site | Barcelona | 8035 | Spain | Details | ||
| GSK Investigational Site | Lerida | 25198 | Spain | Details | ||
| GSK Investigational Site | Manchester | Lancashire | M20 4BX | United Kingdom | Details | |
| GSK Investigational Site | Northwood | Middlesex | HA6 2RN | United Kingdom | Details | |
| GSK Investigational Site | Nottingham | Nottinghamshire | NG5 1PB | United Kingdom | Details | |
| GSK Investigational Site | Glasgow | G12 OYN | United Kingdom | Details | ||
| GSK Investigational Site | London | EC1M 6BQ | United Kingdom | Details | ||
| GSK Investigational Site | London | NW1 2PG | United Kingdom | Details |